Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessEarningsExpect 10-15% growth in FY18: Suven Life Sciences

    Expect 10-15% growth in FY18: Suven Life Sciences

    In an interview with CNBC-TV18, Venkat Jasti, Chairman and CEO at Suven Life Sciences discussed Q3 results and his outlook for the company.

    CNBC-TV18
    January 30, 2018 / 14:41 IST

    In an interview with CNBC-TV18, Venkat Jasti, Chairman and CEO at Suven Life Sciences discussed Q3 results and his outlook for the company.

    Pipeline for Contract research and manufacturing services (CRAMS) business is looking good and we have about 114 active projects on hand, he said.

    Expect 10-15 percent growth in FY18, he added.

    For full interview, watch accompanying video...

    CNBC-TV18
    first published: Jan 30, 2018 02:41 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347